Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic von Brownlee, Wallace, Bourdette, Dennis, Broadley, Simon, Killestein, Joep, Ciccarelli, Olga

Volltext

COVID-19 in multiple sclerosis: The Dutch experience von Loonstra, Floor C, Hoitsma, Elske, van Kempen, Zoé LE, Killestein, Joep, Mostert, Jop P

Volltext

Emerging safety issues in alemtuzumab-treated MS patients von Killestein, Joep, van Oosten, Bob

Volltext

Deep gray matter volume loss drives disability worsening in multiple sclerosis von Eshaghi, Arman, Prados, Ferran, Brownlee, Wallace J., Altmann, Daniel R., Tur, Carmen, Cardoso, M. Jorge, De Angelis, Floriana, van de Pavert, Steven H., Cawley, Niamh, De Stefano, Nicola, Stromillo, M. Laura, Battaglini, Marco, Ruggieri, Serena, Gasperini, Claudio, Filippi, Massimo, Rocca, Maria A., Rovira, Alex, Sastre‐Garriga, Jaume, Vrenken, Hugo, Leurs, Cyra E., Killestein, Joep, Pirpamer, Lukas, Enzinger, Christian, Ourselin, Sebastien, Wheeler‐Kingshott, Claudia A.M. Gandini, Chard, Declan, Thompson, Alan J., Alexander, Daniel C., Barkhof, Frederik, Ciccarelli, Olga

Volltext

PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy von van Oosten, Bob W, Killestein, Joep, Barkhof, Frederik, Polman, Chris H, Wattjes, Mike P

Volltext

Extended dosing of monoclonal antibodies in multiple sclerosis von van Kempen, Zoé LE, Toorop, Alyssa A, Sellebjerg, Finn, Giovannoni, Gavin, Killestein, Joep

Volltext

Imaging of meningeal inflammation should become part of the routine MRI protocol – No von Wattjes, Mike P, Killestein, Joep

Volltext

The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study von Hagens, Marloes H. J., Golla, Sandeep S. V., Janssen, Bieneke, Vugts, Danielle J., Beaino, Wissam, Windhorst, Albert D., O’Brien-Brown, James, Kassiou, Michael, Schuit, Robert C., Schwarte, Lothar A., de Vries, Helga E., Killestein, Joep, Barkhof, Frederik, van Berckel, Bart N. M., Lammertsma, Adriaan A.

Volltext

Information from ecological momentary assessments lead to over-medicalization: Commentary von de Jong, Daan J, Strijbis, Eva M, Killestein, Joep

Volltext

Cannabinoids in the Treatment of Epilepsy von Killestein, Joep, Friedman, Daniel, Devinsky, Orrin

Volltext

Gray matter networks and cognitive impairment in multiple sclerosis von Rimkus, Carolina M, Schoonheim, Menno M, Steenwijk, Martijn D, Vrenken, Hugo, Eijlers, Anand JC, Killestein, Joep, Wattjes, Mike P, Leite, Claudia C, Barkhof, Frederik, Tijms, Betty M

Volltext

PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate von Nieuwkamp, Dennis J, Murk, Jean-Luc, Cremers, Charlotte H.P, Killestein, Joep, Viveen, Marco C, Van Hecke, Wim, Frijlink, Daphne W, Wattjes, Mike P, van Oosten, Bob W

Volltext

The Use of Smartphone Keystroke Dynamics to Passively Monitor Upper Limb and Cognitive Function in Multiple Sclerosis: Longitudinal Analysis von Lam, Ka-Hoo, Twose, James, Lissenberg-Witte, Birgit, Licitra, Giovanni, Meijer, Kim, Uitdehaag, Bernard, De Groot, Vincent, Killestein, Joep

Volltext

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing: NO von van Kempen, Zoé LE, Hogenboom, Laura, Killestein, Joep

Volltext

Disease severity classification using passively collected smartphone-based keystroke dynamics within multiple sclerosis von Hoeijmakers, Aleide, Licitra, Giovanni, Meijer, Kim, Lam, Ka-Hoo, Molenaar, Pam, Strijbis, Eva, Killestein, Joep

Volltext

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment von Leurs, Cyra E, Podlesniy, Petar, Trullas, Ramon, Balk, Lisanne, Steenwijk, Martijn D, Malekzadeh, Arjan, Piehl, Fredrik, Uitdehaag, Bernard MJ, Killestein, Joep, van Horssen, Jack, Teunissen, CE

Volltext

Application of “Mentzer’s PML case definition” to natalizumab-treated patients in the setting of strict MRI-based pharmacovigilance von Wijburg, Martijn T., Warnke, Clemens, Killestein, Joep, Wattjes, Mike P.

Volltext

Oral treatment for multiple sclerosis von Killestein, Joep, Dr, Rudick, Richard A, Prof, Polman, Chris H, Prof

Volltext

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic von van Lierop, Zoë YGJ, Toorop, Alyssa A, van Ballegoij, Wouter JC, Olde Dubbelink, Tom BG, Strijbis, Eva MM, de Jong, Brigit A, van Oosten, Bob W, Moraal, Bastiaan, Teunissen, Charlotte E, Uitdehaag, Bernard MJ, Killestein, Joep, Kempen, Zoé LE van

Volltext

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers von Coric, Danko, Balk, Lisanne J, Verrijp, Merike, Eijlers, Anand, Schoonheim, Menno M, Killestein, Joep, Uitdehaag, Bernard MJ, Petzold, Axel

Volltext